Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03709147||Not yet recruiting||Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma||
||88||All||18 Years to 75 Years (Adult, Older Adult)||NCT03709147||INT 45/18||FAME||October 30, 2018||September 10, 2023||September 10, 2023||October 17, 2018||October 31, 2018||
|2||NCT02185690||Active, not recruiting||A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung||
||Other / Industry||
||13||All||18 Years to 90 Years (Adult, Older Adult)||NCT02185690||CMEK162ACA02T||MEK162||January 11, 2018||June 2019||June 2019||July 9, 2014||May 22, 2019||